@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix schem: . @prefix go: . @prefix obo: . @prefix occursIn: . @prefix species: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 rdf:object go:0008283; rdf:predicate belv:increases; rdf:subject schem:Remnant%20lipoprotein; a rdf:Statement . sub:_2 occursIn: obo:CL_0000192, obo:EFO_0002795, obo:UBERON_0004535, species:10116; rdf:object sub:_1; rdf:predicate belv:decreases; rdf:subject schem:PD%2098%2C059; a rdf:Statement . sub:assertion rdfs:label "a(SCHEM:\"PD 98,059\") -| (a(SCHEM:\"Remnant lipoprotein\") -> bp(GOBP:\"cell proliferation\"))", "a(SCHEM:\"Remnant lipoprotein\") -> bp(GOBP:\"cell proliferation\")" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_4; pav:version "20131211" . sub:_3 prov:value "PD98059, a specific MEK1 inhibitor, and dominant negative Raf-1 significantly inhibited RLP-induced SMC proliferation"; prov:wasQuotedFrom pubmed:15942116 . sub:_4 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:15942116; prov:wasDerivedFrom beldoc:, sub:_3 . } sub:pubinfo { this: dct:created "2014-07-03T14:32:46.085+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }